UNLABELLED: A very large proportion of extremely preterm infants receive treatments for hypotension. There are, however, marked variations in indications for treatment, and in the interventions used, between neonatal intensive care units and between neonatologists. METHODS: We performed systematic reviews of the literature in order to determine which preterm infants may benefit from treatment with interventions to elevate blood pressure (BP), and which interventions improve clinically important outcomes. RESULTS: Our review was not able to define a threshold BP that was significantly predictive of a poor outcome, nor whether any interventions for hypotensive infants improved outcomes, nor which interventions were more likely to be beneficial. CONCLUSIONS: There is a distinct lack of prospective research of this issue, which prevents good clinical care. It is possible that a simple BP threshold that indicates the need for therapy does not exist, and other factors, such as the clinical status or systemic blood flow measurements, may be much more informative. Such a paradigm shift will also require careful prospective study.
UNLABELLED: A very large proportion of extremely preterm infants receive treatments for hypotension. There are, however, marked variations in indications for treatment, and in the interventions used, between neonatal intensive care units and between neonatologists. METHODS: We performed systematic reviews of the literature in order to determine which preterm infants may benefit from treatment with interventions to elevate blood pressure (BP), and which interventions improve clinically important outcomes. RESULTS: Our review was not able to define a threshold BP that was significantly predictive of a poor outcome, nor whether any interventions for hypotensiveinfants improved outcomes, nor which interventions were more likely to be beneficial. CONCLUSIONS: There is a distinct lack of prospective research of this issue, which prevents good clinical care. It is possible that a simple BP threshold that indicates the need for therapy does not exist, and other factors, such as the clinical status or systemic blood flow measurements, may be much more informative. Such a paradigm shift will also require careful prospective study.
Authors: Beau Batton; Lei Li; Nancy S Newman; Abhik Das; Kristi L Watterberg; Bradley A Yoder; Roger G Faix; Matthew M Laughon; Barbara J Stoll; Krisa P Van Meurs; Waldemar A Carlo; Brenda B Poindexter; Edward F Bell; Pablo J Sánchez; Richard A Ehrenkranz; Ronald N Goldberg; Abbot R Laptook; Kathleen A Kennedy; Ivan D Frantz; Seetha Shankaran; Kurt Schibler; Rosemary D Higgins; Michele C Walsh Journal: Pediatrics Date: 2013-05-06 Impact factor: 7.124
Authors: Elysia Adams; Vann Chau; Kenneth J Poskitt; Ruth E Grunau; Anne Synnes; Steven P Miller Journal: J Pediatr Date: 2010-03-15 Impact factor: 4.406
Authors: G Escourrou; L Renesme; E Zana; A Rideau; M O Marcoux; E Lopez; G Gascoin; P Kuhn; P Tourneux; I Guellec; C Flamant Journal: J Perinatol Date: 2017-05-04 Impact factor: 2.521
Authors: Erika Fernandez; Kristi L Watterberg; Roger G Faix; Bradley A Yoder; Michele C Walsh; Conra Backstrom Lacy; Karen A Osborne; Abhik Das; Douglas E Kendrick; Barbara J Stoll; Brenda B Poindexter; Abbot R Laptook; Kathleen A Kennedy; Kurt Schibler; Edward F Bell; Krisa P Van Meurs; Ivan D Frantz; Ronald N Goldberg; Seetha Shankaran; Waldemar A Carlo; Richard A Ehrenkranz; Pablo J Sánchez; Rosemary D Higgins Journal: Am J Perinatol Date: 2015-03-31 Impact factor: 1.862
Authors: Manuel B Schmid; Frank Reister; Benjamin Mayer; Reinhard J Hopfner; Hans Fuchs; Helmut D Hummler Journal: Dtsch Arztebl Int Date: 2013-07-22 Impact factor: 5.594